SILVER SPRING, Md., June 2, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) warns that thermography should not be used in place of mammography for breast cancer screening or diagnosis. FDA says mammography— an X-ray of the breast—is still the most effective way of detecting breast cancer in its earliest stages.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
Thermography produces an infrared image that shows the patterns of heat and blood flow on or near the surface of the body. While cleared by FDA for use as an adjunct, or additional tool, it should not be used by itself to screen for, or diagnose, breast cancer.
The agency has sent several warning letters to health care providers and a thermography manufacturer who claim that the thermal imaging can take the place of mammography.
Learn more about the FDA's concerns about the use of thermography as a screening tool at
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm257499.htm
Sign up for e-mail notices of new FDA Consumer Updates at
https://service.govdelivery.com/service/subscribe.html?code=USFDA_9
View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: [email protected].
Media Contact: Jeffrey Ventura, 301-796-2807, [email protected]
SOURCE U.S. Food and Drug Administration
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article